BioMarin Pharmaceutical(GB:0HNC)
$57.86+0.74 (+1.30%)
GB:0HNC
BioMarin Pharmaceutical ownership
$57.86
At close:+0.74 (+1.30%)
BioMarin Pharmaceutical (0HNC) Ownership - Who Owns BioMarin Pharmaceutical?
2 Followers
BioMarin Pharmaceutical (0HNC) Ownership Overview
- 0.45% Insiders
- 32.46% Mutual Funds
- 5.26% Other Institutional Investors
- 24.17% ETFs
- 37.66% Public Companies and Individual Investors
The ownership structure of BioMarin Pharmaceutical (GB:0HNC) stock is a mix of institutional, retail, and individual investors. Approximately 61.89% of the company’s stock is owned by Institutional Investors, 0.45% is owned by Insiders, and 37.66% is owned by Public Companies and Individual Investors.
The ownership structure of BioMarin Pharmaceutical (GB:0HNC) stock is a mix of institutional, retail, and individual investors. Approximately 61.89% of the company’s stock is owned by Institutional Investors, 0.45% is owned by Insiders, and 37.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 02, 2026 | George Eric Davis | $1,163,678 | |
| May 10, 2026 | Gregory R Friberg | $176,682 | |
| Mar 11, 2026 | Charles Greg Guyer | $996,744 | |
| Feb 25, 2026 | Gregory R Friberg | $381,901 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Entrypoint Capital, Llc | $417,733 | |
| Dec 31, 2025 | Hussman Strategic Advisors Inc | $1,872,045 | |
| Dec 31, 2025 | Fisher Asset Management Llc | $2,097,284 | |
| Dec 31, 2025 | Bridgewater Associates, Lp | $13,666,582 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 20,445,212 | Institution | 10.56% | 1,182,959,966 |
| Vanguard | 16,599,086 | Institution | 8.57% | 960,423,116 |
| Vanguard Index Funds | 15,347,055 | Institution | 7.92% | 887,980,602 |
| John A. Gunn | 14,844,930 | Institution | 7.66% | 858,927,650 |
| Theofanis Kolokotrones | 14,190,183 | Institution | 7.33% | 821,043,988 |
| Ishares | 12,756,263 | Institution | 6.59% | 738,077,377 |
| Dodge & Cox Funds | 11,483,325 | Institution | 5.93% | 664,425,185 |
| Andreas Halvorsen | 7,616,563 | Institution | 3.93% | 440,694,335 |
| Spdr | 6,357,432 | Institution | 3.28% | 367,841,016 |
| Vanguard Horizon Funds | 5,449,401 | Institution | 2.81% | 315,302,342 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 15,347,055 | Institution | 7.92% | 887,980,602 |
| Dodge & Cox Funds | 11,483,325 | Institution | 5.93% | 664,425,185 |
| Vanguard Horizon Funds | 5,449,401 | Institution | 2.81% | 315,302,342 |
| Vanguard Chester Funds | 4,969,450 | Institution | 2.57% | 287,532,377 |
| Fidelity Contrafund | 3,068,493 | Institution | 1.58% | 177,543,005 |
| Capital World Growth & Income Fund | 2,576,251 | Institution | 1.33% | 149,061,883 |
| Primecap Odyssey Funds | 2,385,741 | Institution | 1.23% | 138,038,974 |
| Fidelity Concord Street Trust | 1,901,053 | Institution | 0.98% | 109,994,927 |
| Dfa Investment Dimensions Group Inc | 1,622,377 | Institution | 0.84% | 93,870,733 |
| Fidelity Salem Street Trust | 1,106,222 | Institution | 0.57% | 64,006,005 |
FAQ
Who Owns BioMarin Pharmaceutical (GB:0HNC)?
According to the latest TipRanks data, approximately 61.89% of the company's stock is held by institutional investors, 0.45% is held by insiders, and 37.66% is held by public companies and individual investors.
What percentage of BioMarin Pharmaceutical (GB:0HNC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 61.89% of BioMarin Pharmaceutical (GB:0HNC) stock is held by institutional investors: 32.46% by mutual funds, 24.17% by ETFs and 5.26% by other institutional investors.
What percentage of BioMarin Pharmaceutical (GB:0HNC) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.66% of BioMarin Pharmaceutical (GB:0HNC) stock is held by public companies and individual investors.
Who owns the most shares of BioMarin Pharmaceutical (GB:0HNC)?
BlackRock, Inc. owns the most shares of BioMarin Pharmaceutical (GB:0HNC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
